• Kirin outlined plans to acquire Jamieson Wellness and make it a wholly owned subsidiary, expanding its health science business into North America.
• Planned consideration of CAD 1.9 billion, or CAD 45.75 per share; JPY 218.3 billion equivalent at CAD 1 = JPY 115.
• Transaction structured as a Canadian plan of arrangement; Jamieson’s board supports the deal; closing targeted for Q4 2026.
• Financing planned from cash on hand, cash equivalents, interest-bearing debt; EPS expected to be accretive from fiscal 2027.
• Kirin expects integration under its Kirin Health Science International platform to support global growth across Asia-Oceania and North America.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kirin Holdings Company Limited published the original content used to generate this news brief on August 07, 2026, and is solely responsible for the information contained therein.